Buprenorphine/Naloxone Treatment in Primary Care Is Associated With Decreased Human Immunodeficiency Virus Risk Behaviors
Journal of Substance Abuse Treatment - Netherlands
doi 10.1016/j.jsat.2007.08.004
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2008
Authors
Publisher
Elsevier BV